Status:
UNKNOWN
Effects of Omega-3 EPA/DHA for Soldiers at Risk for Mood Disorders
Lead Sponsor:
United States Department of Defense
Collaborating Sponsors:
GlaxoSmithKline
Conditions:
Mood Disorders
Depression
Eligibility:
All Genders
18-55 years
Phase:
PHASE2
Brief Summary
Stress-related disorders are among the most prevalent and expensive medical consequences of participation in military operations. Omega-3 fatty acids EPA/DHA derived from fish oil are known to benefit...
Eligibility Criteria
Inclusion
- US Army deployed personnel
- score on a mood questionnaire
Exclusion
- currently consume omega-3 fish oil supplements
- are currently taking antidepressant or other medications for psychiatric purposes
- pregnant
- known fish or shellfish allergy
Key Trial Info
Start Date :
November 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2011
Estimated Enrollment :
256 Patients enrolled
Trial Details
Trial ID
NCT01216982
Start Date
November 1 2010
End Date
June 1 2011
Last Update
March 9 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
US Military Base
Camp Taji, Iraq, 09378